The challenges with RATs remain. Hence the evidence provided in RAPs presentation that their real world accuracy is lower than in a clinical setting. RAP recognise the limitations with their tech and have developed their business case accordingly. People who fail to do basic reserach or grasp the pros and cons with each test are a waist of time on these forums ad normally come with a hidden agenda. Good luck to you.
- Forums
- ASX - By Stock
- Ann: ResApp announces positive results of COVID-19 screening test
The challenges with RATs remain. Hence the evidence provided in...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)